Pioglitazone and clarithromycin combined with metronomic low-dose chemotherapy versus nivolumab in patients with advanced non-small cell lung cancer treated in 2nd-line and beyond: Outcomes from a randomized phase II trial (ModuLung)

Heudobler, D. and Schulz, C. and Fischer, J. R. and Staib, P. and Wehler, T. and Suedhoff, T. and Schichtl, T. and Wilke, J. and Hahn, J. and Lueke, F. and Vogelhuber, M. and Klobuch, S. and Pukrop, T. and Herr, W. and Held, S. and Beckers, K. and Bouche, G. and Reichle, A. (2019) Pioglitazone and clarithromycin combined with metronomic low-dose chemotherapy versus nivolumab in patients with advanced non-small cell lung cancer treated in 2nd-line and beyond: Outcomes from a randomized phase II trial (ModuLung). ANNALS OF ONCOLOGY, 30 (Suppl5). pp. 646-647. ISSN 0923-7534, 1569-8041

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Medicine > Lehrstuhl für Innere Medizin II
Depositing User: Dr. Gernot Deinzer
Date Deposited: 24 Mar 2020 12:04
Last Modified: 24 Mar 2020 12:04
URI: https://pred.uni-regensburg.de/id/eprint/26086

Actions (login required)

View Item View Item